Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Review Article

Long Non-Coding RNA GAS5 in Age-Related Diseases

Author(s): Yaqi Wang, Mengzhen Xue, Fangqi Xia, Leiqi Zhu, Dengke Jia, Yan Gao, Luoying Li, Yue Shi, Yuanyang Li, Silong Chen, Guangfu Xu and Chengfu Yuan*

Volume 29, Issue 16, 2022

Published on: 12 January, 2022

Page: [2863 - 2877] Pages: 15

DOI: 10.2174/0929867328666211027123932

Price: $65

Abstract

Aging refers to a natural process and a universal phenomenon in all cells, tissues, organs, and the whole organism. Long non-coding RNAs (lncRNAs) are non-coding RNAs with a length of 200 nucleotides. LncRNA growth arrest-specific 5 (lncRNA GAS5) is often down-regulated in cancer. The accumulation of lncRNA GAS5 has been found to be able to inhibit cancer growth, invasion, and metastasis while enhancing the sensitivity of cells to chemotherapy drugs. LncRNA GAS5 can be a signaling protein, which is specifically transcribed under different triggering conditions. Subsequently, it is involved in signal transmission in numerous pathways as a signal node. LncRNA GAS5, with a close relationship to multiple miRNAs, was suggested to be involved in the signaling pathway under three action modes (i.e., signal, bait, and guidance). LncRNA GAS5 was found to be involved in different age-related diseases (e.g., rheumatoid arthritis, type 2 diabetes, atherosclerosis, osteoarthritis, osteoporosis, multiple sclerosis, cancer, etc.). This study mainly summarized the regulatory effect exerted by lncRNA GAS5 on age-related diseases.

Keywords: lncRNAs , GAS5 , age-related diseases , atherosclerosis , type 2 diabetes mellitus , cancer.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy